Kimberly M. Harkins, MD
Associate Professor
Department:
SOM-Medicine-GSOM
Email:
kharkins@umc.edu
Work Phone:
(601) 984-5770
Education
| University of Mississippi School of Medicine, MD, Medicine | 1996 |
| Mississippi College, BS, Chemistry | 1992 |
| University of Mississippi Medical Center, Internal Medicine | |
| University of Mississippi Medicine Center, Internal Medicine |
Specialty Certification Licensure
| Re-certification, The American Board of Internal Medicine, The American Board of Internal Medicine | 2009 - 2019 |
| Certification, Specialist in Clinical Hypertension, American Society of Hypertension | 2005 - 2015 |
| Licensure, Mississippi State Board of Medical Licensure, Mississippi State Board of Medical Licensure | 06/2000 - 06/2011 |
| Certification, The American Board of Internal Medicine, The American Board of Internal Medicine | 1999 - 2009 |
Current Positions
| Associate Professor, School of Medicine, Department of Medicine | 07/2011 - Present |
| Associate Director, Residency Training Program, School of Medicine, Department of Medicine | 2006 - Present |
| The University of Mississippi Medical Center Jackson, Mississippi 39216 | |
Academic Appointments or Other Previous Appointments
| Assistant Professor, School of Medicine, Department of Medicine | 07/2000 - 06/2011 |
| Co-Director, Residency Training Program, University of Mississippi Medical Center, School of Medicine, Department of Medicine | 2003 - 2006 |
| Associate Director, Residency Training Program, University of Mississippi Medical Center, School of Medicine, Department of Medicine | 2000 - 2003 |
Sponsored Program Funding
| Extramural, A comparison of Prasugrel and Clopidogrel in acute coronary syndrome (ACS) subjects with unstable angina/non-ST elevation myocardial infarction who are medically managed (TRILOGY ACS), Eli Lilly and Company | 08/2008 - 04/2011 |
| Extramural, A Phase III, double-blind, randomized placebo controlled study to evaluate the effects of R04607381 on cardiovascular risk in stable CHD patients with documented recent acute coronary syndrome, Hoffman-LaRoche, Inc. | 06/2008 - 05/2012 |
| Intramural, Investigation of reduction of blood pressure and metabolic rate in obese hypertensive patients using Eplerenone: Implications for treatment of hypertension and heart failure, UMC | 11/2006 - 11/2009 |
| Extramural, A 10-week, multicenter, randomized, double-blind, parallel group, forced titration study using 24 hour ABPM to evaluate the efficacy of a Valsartan/Hydrochlorothiazide treatment regimenh versus conventional treatment regimen with Amlodipine and Hydrochlorothiazide in patients with State 2 Hypertension (EVALUATE), Novartis Pharmaceuticals | 11/2006 - 07/2008 |
| Extramural, A multicenter, randomized, double-blind active controlled study to compare the effect of 24 weeks treatment with Vildagliptin 100 mg qd or Metformin 1500 mg daily in elderly drug naive patients with Type 2 diabetes. (LAF237A), Novartis Pharmaceuticals | 09/2006 - 08/2008 |
| Extramural, A 54-Week, Open Label Multicenter Study to Assess the Long-Term Safety and Combination of Aliskeren 300 mg/Valsartan 320 mg in Patients with Essential Hypertension., Novartis Pharmaceuticals | 07/2006 - 08/2008 |
| Extramural, A 54-week, open label, multicenter study to assess the long term safety and combination of Aliskiren 300 mg/Valsartan 320 mg in patients with essential hypertension (Aliskiren 2301), Novartis Pharmaceuticals | 07/2006 - 08/2008 |
| Extramural, Liraglutide effect and action in diabetes: effect on glycemic control of Liraglutide versus Glimepiride in Type 2 diabetes. A 52-week, double-blind, multicenter, randomized, parallel study to investigate safety and efficacy., Abbott/Covance | 04/2006 - 04/2009 |
| Extramural, A long-term, open-label, safety extension study of the combination of Febofibric Acid and statin therapy for subjects with mixed dyslipidemia (M05-758), Novo Nordisk | 01/2006 - 12/2007 |
| Extramural, A multicenter, randomized, double-blind, prospective study comparing the safety and efficacy of Febofibric Acid and Atorvastatin Calcium combination therapy to Fenofibric Acid and Atorvastatin Calcium Monotherapy in subjects with mixed dyslipidemia (M05-750), Novo Nordisk | 01/2006 - 12/2007 |
| Extramural, A double-blind, randomized, placebo and active controlled, forced titration study evaluating the effects of Nebivolol on blood pressure and heart rate in African American patients with hypertension (NEB 310), Mylan/Bertek Pharmaceuticals | 04/2005 - 03/2007 |
| Extramural, Sub-Investigator, An 8-Week Double-Blind, Multicenter, Randomized, Multifactorial, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aliskiren Administered Alone and in Combination with Hydrochlorothiazide in Patients with Essential Hypertension (“Study 100A”)., Novartis Pharmaceuticals | 07/2004 - 02/2006 |
| Extramural, Clinical Utility of Caduet in Simultaneously Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population (Capable), Pfizer | 05/2004 - 12/2005 |
| Extramural, A prospective, multinational, multicenter, double-blind, randomized, active-controlled trial to compare the effects of Lotrel (amlodipine/benazepril) to Benazepril and Hydrochlorothiazide combined on the reduction of cardiovascular morbidity and mortality in patients with high risk hypertension., Novartis Pharmaceuticals | 10/2003 - 06/2009 |
| Extramural, Sub-Investigator - A prospective, multinational, multicenter, double-blind, randomized, active-controlled trial to compare the effects of Lotrel (amlodipine/benazepril) to Benaepril and Hydrochlorothiazide Combined on the Reduction of Cardiovascular Morbidity and Mortality in Patients with High Risk Hypertension. (Accomplish), Novartis. | 10/2003 - 06/2009 |
| Extramural, A Multi-Center, Randomized, Double-Blind, Double-Dummy Study Evaluating the Safety and Efficacy of the Addition of Amlodipine to Quinapril or Losartan in the Treatment of Diabetic Hypertensive Subjects. (Adhere) $25,000. (4/03 - 4/05), Pfizer | 04/2003 - 04/2005 |
| Extramural, Sub-Investigator - A Phase 3, Randomized, Triple-Blind, Parallel-Group, Long-Term, Placebo-Controlled, Multicenter Study to Examine the Effect on Glucose Control (HbA1c) of AC2993 Given Two Times a Day in Subjects with Type 2 Diabetes Mellitus Treated with Sulfonylurea Alone. (Amylin 113), Amylin Pharmaceuticals. | 04/2003 - 12/2003 |
| Extramural, Sub-Investigator - A Double-Blind, Randomized, Vehicle-Controlled Study Comparing the Safety and Efficacy of Benzydamine Hydrochloride 0.15% Oral Rinse Including a Separate Open-Label Standard of Care Arm in Subjects with Radiation-Induced Oral Mucositis. (Mucositis) $117,375. (3/03 - 3/04)., McNeil Consumer & Specialty Pharmaceuticals. | 03/2003 - 03/2004 |
| Extramural, Sub-Investigator - A Randomized, Double-Blind, Multicenter, Multifactorial, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients, Novartis Pharmaceuticals | 10/2002 - 10/2004 |
| Extramural, Sub-Investigator - Dose Finding, Efficacy, and Safety of AZ 242 in Subjects with Type 2 diabetes, Protocol 270. (Glad/270), AstraZeneca | 08/2002 - 08/2003 |
| Extramural, Sub-Investigator - A 6-week, Randomized, Open-Label, Comparative Study to Evaluate the Efficacy and Safety of Rosuvastatin and Atorvastatin in the Treatment of Hypercholesterolemia in African American Subjects, AstraZeneca | 06/2002 - 12/2003 |
| Extramural, Sub-Investigator - A Phase 3, Randomized, Triple-Blind, Parallel-Group, Long-Term, Placebo-Controlled, Multicenter Study to Examine the Effect on Glucose Control (HbA1c) of AC2993 Given Two Times a Day in Subjects with Type 2 Diabetes Mellitus Treated with Metformin and a Sulfonylurea., Amylin Pharmaceuticals | 05/2002 - 02/2004 |
| Extramural, Sub-Investigator - A Phase 3, Randomized, Triple-Blind, Parallel-Group, Long-Term, Placebo-Controlled, Multicenter Study to Examine the Effect on Glucose Control (HbA1c), of AC2993 Given Two Times a Day in Subjects with Type 2 Diabetes Mellitus Treated with Metformin Alone, Amylin Pharmaceuticals | 04/2002 - 12/2003 |
| Extramural, Sub-Investigator, DioVan Antihypertensive Long-Term Use Evaluation: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Active-Controlled Trial in Patients with Essential Hypertension to Compare the Effect of Valsartan 80 and 160 mg, with or without the addition of hydrochlorothiazide, once daily to that of amlodipine 5 and 10 mg once daily, with or without the addition of hydrochlorothiazide, on cardiovascular morbidity and mortality (VALUE Study)., Novartis Pharmaceuticals | 03/2002 - 03/2005 |
| Extramural, Sub-Investigator, A Multicenter, Double-Blind, Randomized Study to Evaluate the Effects of Valsartan and the Combination of Valsartan and Simvastatin on Blood Pressure (Ambulatory and Standard Cuff) and on Selected Biochemical Markets of Endothelial Function, Safety and Tolerability (VAS Study) $66,523 (3/02 - 3/03), Novartis Pharmaceuticals. | 03/2002 - 03/2003 |
| Extramural, Sub-Investigator, A Randomized, Multicenter, Double-Blind, Parallel Group Study to Determine the Efficacy and Safety of Lotrel versus Enalapril in the Treatment of Hypertension in an African-American Population with Type 2 Diabetes (Lotrel Study), Novartis Pharmaceuticals | 02/2002 - 10/2003 |
| Extramural, A randomized, double-blind, placebo-controlled, multicenter study of the efficacy and safety of long term administration of Nateglinide and Valsartan in the prevention of diabetes and cardiovascular outcomes in subjects with imparied glucose tolerance, Novartis Pharmaceuticals | 12/2001 - 09/2009 |
| Extramural, Sub-Investigator, Pravastatin or Atorvastatin Evaluation and Infection Therapy (Prove It), Bristol-Myers Squibb | 09/2001 - 09/2004 |
| Extramural, Sub-Investigator, Antihypertensive Efficacy of Adding Candesartan Cilexetil to Lisinopril in Comparison to Up-titration of Lisinopril (AMAZE), Astra Zeneca | 09/2001 - 09/2002 |
| Extramural, Sub-Investigator, Multicenter, Randomized, Double-Blind, Placebo-Controlled and Open-Label Evaluation of the Safety and Efficacy of Dual therapy with Atorvastatin Plus Amlodipine When Compared to Either Therapy Alone in the Treatment of Patients with Simultaneous Hyperlipidemia and Hypertension (The AVALON Study), Pfizer Pharmaceuticals. | 01/2001 - 07/2003 |
| Extramural, Sub-Investigator, A Multicenter, Randomized, Double-Blind, Active Control Trial to Evaluate the Safety and Efficacy of Metformin/Glyburide Tablets as First Line Therapy in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control with Diet and Exercise (CV138-054), Bristol-Myers Squibb | 07/2000 - 03/2001 |
| Extramural, Sub-Investigator, A Multicenter, Randomized, Double-Blind, Parallel Group Trial Comparing the Safety and Efficacy of Metformin/Glyburide to Pioglitazone as First Line Therapy in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control with Diet and Exercise (CV138-056), Bristol-Myers Squibb. | 06/2000 - 03/2001 |
| Extramural, Sub-Investigator, Clinical Protocol for a Double-Blind, Randomized, Placebo and Active-Controlled Comparison Study of the Antihypertensive Effect and Safety of Eplerenone Versus Placebo and Versus Losartan in Black and White Hypertensive Patients (020), G. D. Searle | 11/1999 - 12/2000 |
| Extramural, Sub-Investigator, A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Long-Term Trial of Preventing Hypertension Using Candesartan Cilexetil 16mg in Patients with High Normal Blood Pressure (TROPHY)., AstraZeneca | 03/1998 - 03/2004 |
Publications
Journal Article | |
| Wofford MR, Miller-Davis M, Harkins KG, King DS, Wyatt SB, Jones DW Therapeutic Considerations in the Treatment of Obesity Hypertension J Clin Hypertens | 2002 |
Abstracts | |
| Long RC, King DS, Wofford MR, Harkins KG, Stewart JL Hepatocellular Necrosis Associated with Labetalol Am J Hypertens | 2005 |
| Wofford MR, King DS, Harkins KG, Stewart JL, Noble SL, Usery JB, Shimozono T Incidence of Hyperkalemia Associated with Aldosterone Antagonists in a Hypertension Referral Center Am J Hypertens | 2005 |
| King DS, Barud SJ, Wofford MR, Noble SL, Fontenot TM, Reed RR, Harkins KG, Stewart JL, Wyatt SB, McDaniel A Improving Medication Adherence in a Southeastern Hypertension Clinic Using Adhererx. Am J Hypertens | 2004 |
| Barud SJ, King DS, Reed RR, Harkins KG, Wofford MR, Noble SL Screening for Depression and Anxiety in a Hypertension Specialty Clinic. Am J Hypertens | 2004 |
| Stewart JL, Harkins K, King D, Wofford M The Effects of Extended Duty Hours on Ambulatory Blood Pressures in Internal Medicine, Pediatric, and Med-Peds Residents. Am J Hypertens | 2004 |
| Reed RR, King DS, Wofford MR, Adair CM, Harkins KG, Stewart JL, Wyatt SB, Harrell TK Variations in Blood Pressure Control Throughout the Dosing Interval with Morning Versus Evening Dosing of Once-Daily Antihypertensive Medications Am J Hypertens | 2004 |
| Wofford MR, King DS, Habeeb GE, Harkins KG, Stewart JL, Wyatt SB Long-term management of hypertensive patients with primary aldosteronism. Am J Hypertens | 2003 |
| King DS, Thomas JR, Habeeb GE, Harkins KG, Harrell TK, Noble SL, Stewart JL, Wofford MR, Wyatt SB, Smith M, Owens B Medication adherence in a southeastern hypertension clinic Am J Hypertens | 2003 |
| Thomas JR, King DS, Wofford MR, Habeeb, GE, Harkins KG, Stewart JL, Wyatt SB, Noble SL Strategies for increasing influenza vaccination rates among a high-risk cardiovascular population Am J Hypertens | 2003 |
| Harkins KG, King DS, Habeeb GE, Stewart JL, Wyatt SB, Wofford MR Use of a long-acting loop diuretic to improve blood pressure control. Am J Hypertens | 2003 |
| Wofford MR, Harkins KG, King DS, Habeeb GE, Wyatt SB, Jones DW Accurate Cuff Size in Blood Pressure Measurement. American Journal of Hypertension | 2002 |
| King DS, Wofford MR, Wyatt SB, Habeeb GE, Harkins KG, Harrell TK, Jones DW, Sucher B, Noble SL Assessing Health Awareness in Patients with Hypertension American Journal of Hypertension | 2002 |
| Wyatt SB, Harkins KG, King DS, Wofford MR, Jones DW Invoking Source of Spiritual Sustenance as a Treatment Strategy in African Americans with Hypertension American Journal of Hypertension | 2002 |
| King DS, Jones DW, Harkins KG, Harrell TK, Kelly KW Cognitive Impairment Associated with Atorvastatin. Pharmacotherapy | 2001 |
| Harkins KG, King DS, Wofford MR, Wyatt SB, Jones DW Iatrogenic Hypotension Associated with Normal-Tension Glaucoma. Am J Hypertension | 2001 |
| King DS, Jones DW, Wofford MR, Wyatt SB, Tidwell BH, Harkins KG, Harrell TK Pilot Project for Reduction of Cardiovascular Disease in Mississippi Rural Communities Am J Hypertension | 2001 |
| Wyatt SB, Harkins KG, King DS, Wofford MR, Jones DW Prevalence of Secondary Hypertension in a Southeastern US Hypertension Referral Center Am J Hypertension | 2001 |
| Wofford MR, King DS, Wyatt SB, Harkins KG, Kelly KW, Jones DW Screening for Obstructive Sleep Apnea (OSA) in Patients with Hypertension Am J Hypertension | 2001 |
| King DS, Kelley KW, Wyatt SB, Wofford MR, Harkins KG, Jones DW Utility of Ambulatory Blood Pressure Monitoring in a Hypertension Specialty Clinic Am J Hypertension | 2001 |
| King DS, Noble SL, Harkins KG, Wofford MR, Harrell TK, Ramsey LA, Replogle WH, Tidwell BH Evaluation of Compliance with National Cholesterol Education Program Recommendations for Screening and Treatment of Hyperlipidemia in Medical Resident Primary Care Training Clinics Pharmacotherapy | 2000 |
| Harkins KG, King DS, Wofford MR, Brown CA, Wyatt SB, Miller-Davis ME, Ramsey LA, Jones DW Screening for Dyslipidemia in Resident Training Clinics: Is Cardiovascular Risk Management Adequate? Am J Hypertension | 2000 |
| Wofford MR, Harkins KG, King DS, Wyatt SB, Jones DW Screening for Primary Aldosterone in Older Patients with Hypertension Am J Hypertension | 2000 |
| Wofford MR, Davis MM, Harkins KG, King DS, Warnock JL, Wyatt SB, Jones DW Screening for Primary Aldosteronism in Hypertensive Patients Am J Hypertension | 2000 |
| Harkins KG, Schlessinger S An Unusual Case of Carotid Hypersensitivity Journal of the Mississippi State Medical Association | 1999 |
Book Chapter | |
| Jackson D, Harkins KG A 22-year-old woman with dizziness Hypertension Pearls. Philadelphia, Hanley & Belfus, Inc | 2004 |
| Rogers H, Harkins KG A 32-year-old woman with newly diagnosed hypertension Hypertension Pearls. Philadelphia, Hanley & Belfus, Inc | 2004 |
| Habeeb GH, Harkins KG A 44-year-old woman with hematuria Hypertension Pearls. Philadelphia, Hanley & Belfus, Inc | 2004 |
| Wood RL, Harkins KG A 46-year-old woman with anxiety Hypertension Pearls. Philadelphia, Hanley & Belfus | 2004 |
| Harkins KG A 48-year-old man with diabetes and swollen ankles Hypertension Pearls. Philadelphia, Hanley & Belfus, Inc | 2004 |
| Hubanks J, Andrews B, Harkins KH A 56-year-old man with nausea, diaphoresis, and extreme hypertension Hypertension Pearls. Philadelphia, Hanley & Belfus, Inc. | 2004 |
| Habeeb GH, Harkins KG A 60-year-old man with hematuria and flank pain Hypertension Pearls. Philadelphia, Hanley & Belfus, Inc | 2004 |
| Habeeb GH, Harkins KG A 62-year-old woman with uncontrolled hypertension Hypertension Pearls. Philadelphia, Hanley & Belfus, Inc | 2004 |
| Mehrle A, Harkins KG A 66-year-old woman with dyspnea Hypertension Pearls. Philadelphia, Hanley & Belfus, Inc. 2004;1-4 | 2004 |
| Harkins KG A 67-year-old man with a broken hip and ankle Hypertension Pearls. Philadelphia, Hanley & Belfus, Inc | 2004 |
| Habeeb GH, Harkins KG A 67-year-old woman with hypertension and headaches Hypertension Pearls. Philadelphia, Hanley & Belfus | 2004 |
| Kelley KW, Harkins KG A 69-year-old woman with resistant hypertension Hypertension Pearls. Philadelphia, Hanley & Belfus, Inc | 2004 |
| Habeeb GH, Harkins KG A 72-year-old man with hypertension and renal insufficiency Hypertension Pearls. Philadelphia, Hanley & Belfus, Inc | 2004 |
| Noble SL, Watts SA, Harkins KG An 80-year-old woman with chronic knee pain Hypertension Pearls. Philadelphia, Hanley & Belfus | 2004 |
Presentations
| Poster Presentation, Long-term management of hypertensive patients with primary aldosteronism, 18th Scientific Meeting of the American Society of Hypertension, New York, NY | 05/2003 |
| Poster Presentation, Medication adherence in a southeastern hypertension clinic., 18th Scientific Meeting of the American Society of Hypertension, New York, NY | 05/2003 |
| Poster Presentation, Strategies for increasing influenza vaccination rates among a high-risk cardiovascular population, 18th Scientific Meeting of the American Society of Hypertension, New York, NY | 05/2003 |
| Poster Presentation, Use of a long-acting loop diuretic to improve blood pressure control., ing18th Scientific Meet of the American Society of Hypertension, New York, NY | 05/2003 |
| Ambulatory Grand Rounds, “Initial Therapy for Hypertension: JNC1 to ALLHAT and Beyond.”, Department of Internal Medicine, University of Mississippi Medical Center, University of Mississippi Medical Center | 03/2003 |
| Poster Presentation, Accurate Cuff Size in Blood Pressure Measurement. American Society of Hypertension 17th Annual Scientific Meeting, American Society of Hypertension, New York, New York | 05/2002 |
| Poster Presentation, Assessing Health Awareness in Patients with Hypertension, American Society of Hypertension 17th Annual Scientific Meeting, New York, New York | 05/2002 |
| Poster Presentation, Invoking Source of Spiritual Sustenance as a Treatment Strategy in African Americans with Hypertension., American Society of Hypertension 17th Annual Scientific Meeting, New York, New York | 05/2002 |
| Poster Presentation, Screening for Primary Aldosterone in Older Patients with Hypertension. 16th Scientific meeting of the American Society of Hypertension, San Francisco, CA, May, 2001., 16th Scientific meeting of the American Society of Hypertension, San Francisco, CA | 05/2001 |
| Poster Presentation, Evaluation of Compliance with National Cholesterol Education Program Recommendations for Screening and Treatment of Hyperlipidemia in Medical Resident Primary Care Training Clinics, 15th Scientific Meeting of the American Society of Hypertension, New, New York, New York | 05/2000 |
| Regional Invited Seminars/Lectures, “Carotid Sinus Hypersensitivity and Syncope.”, Regional American College of Physicians Meeting, NewOrleans, Louisiana | 03/1999 |
| State/Local Invited Seminars/Lectures, “Traditional Risk Factors for Coronary Artery Disease.”, Department of Internal Medicine, University of Mississippi Medical Center, University of Mississippi Medical Center | 05/1998 |
| Regional Invited Seminars/Lectures, Mississippi-Louisiana Regional American College of Physicians, Jackson, MS | 03/1998 |
| State/Local Invited Seminars/Lectures, “A Case of Severe Envenomation.”, American College of Physicians Associates, Jackson, MS | 11/1997 |
| Poster Presentation, “Prevalence of Sexual Assault Among Family Practice Patients.”, The College of Family Physicians of Canada, Banff, Alberta, Canada | 04/1994 |
Honors, Awards, and Recognition
| Best Doctors in America | 2011 |
| Best Doctors In America | 2003 |
| Ottilie Schillig Memorial Scholarship, University of Mississippi School of Medicine | 1992 |
| European School of European Medicine (ESIM), European School of Internal Medicine (ESIM, Alicante, Spain | |
| American Board of Internal Medicine-Representative, American Board of Internal Medicine | |
| Bristol Myers Squibb Recognition Award, American Society of Hypertension | |
| Alpha Omega Alpha Resident of the Year, University of Mississippi Medical Center | |
| Nelson Scholar (Valedictorian), Mississippi College | |
| Perry Academic Award in Chemistry, Mississippi College |
Professional Membership and Service
| American Society of Hypertension Spcialist in Clinical Hypertension, Specialist in Clinical Hypertension, Specialist Exam | 2005 - Present |
| Gulf Central Regional Chapter, Member | 2000 - Present |
| American College of Physicians, Member | |
| American Society of Hypertension, Member | |
| Christian Medical and Dental Society, Member |
Committee Service
| Department of Medicine Clinical Council, Member | 2011 - 2012 |
| University Of Mississippi Medical Center Executive Committee, Member-at-Large | 2009 - 2011 |
| University of Mississippi Medical Center Staff, Secretary | 2008 - 2009 |
| University of Mississippi Medical Center Staff, Secretary | 2003 - 2004 |
| Education Committee, Member | 2000 - Present |
| School Of Medicine - Residency Review Subcommittee, Member | 2000 - 2005 |
| School Of Medicine - Graduate Medical Education, Member | 2000 - 2003 |
| The University Hospitals and Clinics - Medical Records, Member | 1999 - 2001 |
Other Service
| Residency Training Program, Co-Director |
Teaching Experience
| 621, Medicine, Course, Guest Presenter, Introduction to Clinical Medicine | Fall 2010 |
| 621, Medicine, Course, Preceptor, Introduction to Clinical Medicine | Fall 2010 |
Residency Training
| Internal Medicine Rsdidency Training Program, Assoc. Program Director | 2000 - Present |